Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,430,907
Percent of class
10.3400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000846087-23-000154
Form type
SC 13G/A
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
Feb 06, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub